Skip to content
StockMarketAgent
§ How we look at hyper-growth

High revenue growth, often unprofitable on GAAP. We use reverse-DCF as the primary lens: what does the current price imply about long-run growth and margins? If the implied path is heroic, we underweight.

Top by upside
LLY
+50.3%
Eli Lilly and Company
strong-buy· 2026-05-08
NVDA
+21.7%
NVIDIA Corporation
buy· 2026-05-07
PLTR
+9.7%
Palantir Technologies Inc.
hold· 2026-05-07